Gujarat Themis Biosyn Intrinsic Value
Gujarat Themis Biosyn (GUJTHEM) median intrinsic value is ₹294.55 from 9 valuation models (range ₹117–₹973), vs current price ₹389.35 — -24.3% downside (Trading Above Calculated Value), margin of safety -32.2%. For current market price and key ratios, visit Gujarat Themis Biosyn share price chart.
GUJTHEM Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Themis Biosyn intrinsic value across 9 models vs current price ₹389.35 — upside/downside and value range per method. Also explore GUJTHEM stock price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹116.81 | ₹93.45 - ₹140.17 | -70.0% | EPS: ₹4.40, Sector P/E: 22x |
| Book Value Method | asset | ₹450.91 | ₹405.82 - ₹496.00 | +15.8% | Book Value/Share: ₹225.45, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹294.55 | ₹265.10 - ₹324.01 | -24.3% | Revenue/Share: ₹147.27, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹681.82 | ₹613.64 - ₹750.00 | +75.1% | EBITDA: ₹75.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹973.38 | ₹778.70 - ₹1168.06 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹116.81 | ₹105.13 - ₹128.49 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹116.81 | ₹105.13 - ₹128.49 | -70.0% | Revenue Growth: 8.0%, Adj P/E: 15.6x |
| ROE Based Valuation | profitability | ₹610.91 | ₹549.82 - ₹672.00 | +56.9% | ROE: 19.4%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹149.40 | ₹134.46 - ₹164.34 | -61.6% | EPS: ₹4.40, BVPS: ₹225.45 |
GUJTHEM Intrinsic Value vs Market Price — All Valuation Models
Gujarat Themis Biosyn fair value range ₹117–₹973 vs current market price ₹389.35 across 9 valuation models. Browse GUJTHEM income statement for revenue, profit, balance sheet and cash flow data.
GUJTHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Themis Biosyn median intrinsic value ₹294.55, current price ₹389.35 — Trading Above Calculated Value by 24.3%, margin of safety -32.2%.
What is the intrinsic value of GUJTHEM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gujarat Themis Biosyn (GUJTHEM) is ₹294.55 (median value). With the current market price of ₹389.35, this represents a -24.3% variance from our estimated fair value.
The valuation range spans from ₹116.81 to ₹973.38, indicating ₹116.81 - ₹973.38.
Is GUJTHEM undervalued or overvalued?
Based on our multi-method analysis, Gujarat Themis Biosyn (GUJTHEM) appears to be trading above calculated value by approximately 24.3%.
GUJTHEM Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Themis Biosyn financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.62 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 19.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 45.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.54x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GUJTHEM Cash Flow Quality — Operating & Free Cash Flow
Gujarat Themis Biosyn operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹91 Cr | ₹35 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹40 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹40 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |